None of the 10 search results mention "F45G2.8 Antibody" explicitly. The sources focus on topics such as:
General antibody structure (e.g., Fab/Fc regions, IgG subtypes) .
Disease-specific antibodies (e.g., anti-AChR in myasthenia gravis , anti-Dengue antibodies ).
Commercial antibodies (e.g., CD45.2 clones like 104 , SARS-CoV-2 neutralizing antibodies ).
This suggests that either:
The identifier "F45G2.8" is a non-standard or internal nomenclature.
The antibody is highly specialized or newly characterized and not yet widely reported.
The naming convention "F45G2.8" does not align with standard antibody classification systems observed in the literature. For example:
Clone numbers: Many antibodies use numeric/alphabetic codes (e.g., "104" for CD45.2 , "4G2" for Dengue virus ).
Epitope specificity: Antibodies are often named by target (e.g., "anti-AChR" , "anti-FcRn" ).
Format descriptors: Some include tags like "BUV805" for fluorophores or "N297Q" for Fc-engineered variants .
If "F45G2.8" refers to a clone, target, or engineering feature, additional context is needed to align it with known data.
To resolve this ambiguity:
Verify the identifier: Confirm whether "F45G2.8" corresponds to a clone ID, catalog number, or target antigen.
Consult specialized databases: Search repositories like:
UniProt (antibody-specific entries).
The Antibody Registry (https://antibodyregistry.org).
CiteAb (commercial antibody database).
Review patent literature: Novel antibodies may be disclosed in patents before peer-reviewed publication.
While "F45G2.8" is not documented, analogous identifiers in the search results include:
| Antibody Name | Target/Function | Source |
|---|---|---|
| 104 | Mouse CD45.2 | |
| 4G2 | Dengue virus E protein | |
| COV2-2676 | SARS-CoV-2 spike N-terminal domain | |
| E60-N297Q | Fc-engineered anti-Dengue therapeutic |
If "F45G2.8" follows conventions from the search results, it might: